FRANKLIN LAKES, N.J. , April 20, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ), a leading global medical technology company, is voluntarily recalling specified lots of the ChloraPrep ™ Hi-Lite Orange™ 26 mL Applicator (2% w/w chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol
Company continues its commitment to expanding health care access through its long-standing support of UNICEF USA and their efforts to eliminate Maternal and Neonatal Tetanus FRANKLIN LAKES, N.J. , April 20, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global
Clearance supported by clinical data from a feasibility study with favorable primary patency rates observed out to 180 days FRANKLIN LAKES, N.J. , April 14, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced it has
WHO Rapid Communication cites high accuracy for the detection of TB, rifampicin and isoniazid resistance on respiratory samples FRANKLIN LAKES, N.J. , April 13, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced that
FRANKLIN LAKES, N.J. , April 5, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE:BDX) announced today that it will report its financial results for the second quarter of fiscal year 2021 on Thursday, May 6, 2021 . BD will issue a press release detailing the quarter's results, along
TUCSON, Ariz. , April 1, 2021 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, announced today it will invest $65 million to construct a state-of-the-art facility in Tucson, Arizona that will be a hub for the company's supply chain,